Granulocyte Macrophage Colony Stimulating Factor Market, Global Outlook and Forecast 2022-2028
Report Code: KNJ1281440 No. of Pages: 71 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Granulocyte Macrophage Colony Stimulating Factor in global, including the following market information:
Global Granulocyte Macrophage Colony Stimulating Factor Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Granulocyte Macrophage Colony Stimulating Factor Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Granulocyte Macrophage Colony Stimulating Factor companies in 2021 (%)
The global Granulocyte Macrophage Colony Stimulating Factor market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
CG-0070 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Granulocyte Macrophage Colony Stimulating Factor include Aduro BioTech Inc, Amgen Inc, BriaCell Therapeutics Corp, Cold Genesys Inc, GlaxoSmithKline Plc, Humanigen Inc, Mologen AG, Morphotek Inc and Sillajen Biotherapeutics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Granulocyte Macrophage Colony Stimulating Factor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Granulocyte Macrophage Colony Stimulating Factor Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Granulocyte Macrophage Colony Stimulating Factor Market Segment Percentages, by Type, 2021 (%)
CG-0070
Gimsilumab
GSK-3196165
Lenzilumab
MGN-1601
Others
Global Granulocyte Macrophage Colony Stimulating Factor Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Granulocyte Macrophage Colony Stimulating Factor Market Segment Percentages, by Application, 2021 (%)
Solid Tumor
Lymphoma
Kidney Cancer
Lung Disease
Others
Global Granulocyte Macrophage Colony Stimulating Factor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Granulocyte Macrophage Colony Stimulating Factor Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Granulocyte Macrophage Colony Stimulating Factor revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Granulocyte Macrophage Colony Stimulating Factor revenues share in global market, 2021 (%)
Key companies Granulocyte Macrophage Colony Stimulating Factor sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Granulocyte Macrophage Colony Stimulating Factor sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aduro BioTech Inc
Amgen Inc
BriaCell Therapeutics Corp
Cold Genesys Inc
GlaxoSmithKline Plc
Humanigen Inc
Mologen AG
Morphotek Inc
Sillajen Biotherapeutics
Takeda Pharmaceutical Co Ltd
1 Introduction to Research & Analysis Reports
1.1 Granulocyte Macrophage Colony Stimulating Factor Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Granulocyte Macrophage Colony Stimulating Factor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Granulocyte Macrophage Colony Stimulating Factor Overall Market Size
2.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size: 2021 VS 2028
2.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Granulocyte Macrophage Colony Stimulating Factor Sales: 2017-2028
3 Company Landscape
3.1 Top Granulocyte Macrophage Colony Stimulating Factor Players in Global Market
3.2 Top Global Granulocyte Macrophage Colony Stimulating Factor Companies Ranked by Revenue
3.3 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Companies
3.4 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Companies
3.5 Global Granulocyte Macrophage Colony Stimulating Factor Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Granulocyte Macrophage Colony Stimulating Factor Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Granulocyte Macrophage Colony Stimulating Factor Product Type
3.8 Tier 1, Tier 2 and Tier 3 Granulocyte Macrophage Colony Stimulating Factor Players in Global Market
3.8.1 List of Global Tier 1 Granulocyte Macrophage Colony Stimulating Factor Companies
3.8.2 List of Global Tier 2 and Tier 3 Granulocyte Macrophage Colony Stimulating Factor Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Granulocyte Macrophage Colony Stimulating Factor Market Size Markets, 2021 & 2028
4.1.2 CG-0070
4.1.3 Gimsilumab
4.1.4 GSK-3196165
4.1.5 Lenzilumab
4.1.6 MGN-1601
4.1.7 Others
4.2 By Type - Global Granulocyte Macrophage Colony Stimulating Factor Revenue & Forecasts
4.2.1 By Type - Global Granulocyte Macrophage Colony Stimulating Factor Revenue, 2017-2022
4.2.2 By Type - Global Granulocyte Macrophage Colony Stimulating Factor Revenue, 2023-2028
4.2.3 By Type - Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share, 2017-2028
4.3 By Type - Global Granulocyte Macrophage Colony Stimulating Factor Sales & Forecasts
4.3.1 By Type - Global Granulocyte Macrophage Colony Stimulating Factor Sales, 2017-2022
4.3.2 By Type - Global Granulocyte Macrophage Colony Stimulating Factor Sales, 2023-2028
4.3.3 By Type - Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share, 2017-2028
4.4 By Type - Global Granulocyte Macrophage Colony Stimulating Factor Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Granulocyte Macrophage Colony Stimulating Factor Market Size, 2021 & 2028
5.1.2 Solid Tumor
5.1.3 Lymphoma
5.1.4 Kidney Cancer
5.1.5 Lung Disease
5.1.6 Others
5.2 By Application - Global Granulocyte Macrophage Colony Stimulating Factor Revenue & Forecasts
5.2.1 By Application - Global Granulocyte Macrophage Colony Stimulating Factor Revenue, 2017-2022
5.2.2 By Application - Global Granulocyte Macrophage Colony Stimulating Factor Revenue, 2023-2028
5.2.3 By Application - Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share, 2017-2028
5.3 By Application - Global Granulocyte Macrophage Colony Stimulating Factor Sales & Forecasts
5.3.1 By Application - Global Granulocyte Macrophage Colony Stimulating Factor Sales, 2017-2022
5.3.2 By Application - Global Granulocyte Macrophage Colony Stimulating Factor Sales, 2023-2028
5.3.3 By Application - Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share, 2017-2028
5.4 By Application - Global Granulocyte Macrophage Colony Stimulating Factor Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Granulocyte Macrophage Colony Stimulating Factor Market Size, 2021 & 2028
6.2 By Region - Global Granulocyte Macrophage Colony Stimulating Factor Revenue & Forecasts
6.2.1 By Region - Global Granulocyte Macrophage Colony Stimulating Factor Revenue, 2017-2022
6.2.2 By Region - Global Granulocyte Macrophage Colony Stimulating Factor Revenue, 2023-2028
6.2.3 By Region - Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share, 2017-2028
6.3 By Region - Global Granulocyte Macrophage Colony Stimulating Factor Sales & Forecasts
6.3.1 By Region - Global Granulocyte Macrophage Colony Stimulating Factor Sales, 2017-2022
6.3.2 By Region - Global Granulocyte Macrophage Colony Stimulating Factor Sales, 2023-2028
6.3.3 By Region - Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Granulocyte Macrophage Colony Stimulating Factor Revenue, 2017-2028
6.4.2 By Country - North America Granulocyte Macrophage Colony Stimulating Factor Sales, 2017-2028
6.4.3 US Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.4.4 Canada Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.4.5 Mexico Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Granulocyte Macrophage Colony Stimulating Factor Revenue, 2017-2028
6.5.2 By Country - Europe Granulocyte Macrophage Colony Stimulating Factor Sales, 2017-2028
6.5.3 Germany Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.5.4 France Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.5.5 U.K. Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.5.6 Italy Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.5.7 Russia Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.5.8 Nordic Countries Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.5.9 Benelux Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Granulocyte Macrophage Colony Stimulating Factor Revenue, 2017-2028
6.6.2 By Region - Asia Granulocyte Macrophage Colony Stimulating Factor Sales, 2017-2028
6.6.3 China Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.6.4 Japan Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.6.5 South Korea Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.6.6 Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.6.7 India Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Granulocyte Macrophage Colony Stimulating Factor Revenue, 2017-2028
6.7.2 By Country - South America Granulocyte Macrophage Colony Stimulating Factor Sales, 2017-2028
6.7.3 Brazil Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.7.4 Argentina Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales, 2017-2028
6.8.3 Turkey Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.8.4 Israel Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.8.5 Saudi Arabia Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
6.8.6 UAE Granulocyte Macrophage Colony Stimulating Factor Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Aduro BioTech Inc
7.1.1 Aduro BioTech Inc Corporate Summary
7.1.2 Aduro BioTech Inc Business Overview
7.1.3 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Major Product Offerings
7.1.4 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales and Revenue in Global (2017-2022)
7.1.5 Aduro BioTech Inc Key News
7.2 Amgen Inc
7.2.1 Amgen Inc Corporate Summary
7.2.2 Amgen Inc Business Overview
7.2.3 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Major Product Offerings
7.2.4 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales and Revenue in Global (2017-2022)
7.2.5 Amgen Inc Key News
7.3 BriaCell Therapeutics Corp
7.3.1 BriaCell Therapeutics Corp Corporate Summary
7.3.2 BriaCell Therapeutics Corp Business Overview
7.3.3 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Major Product Offerings
7.3.4 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales and Revenue in Global (2017-2022)
7.3.5 BriaCell Therapeutics Corp Key News
7.4 Cold Genesys Inc
7.4.1 Cold Genesys Inc Corporate Summary
7.4.2 Cold Genesys Inc Business Overview
7.4.3 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Major Product Offerings
7.4.4 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales and Revenue in Global (2017-2022)
7.4.5 Cold Genesys Inc Key News
7.5 GlaxoSmithKline Plc
7.5.1 GlaxoSmithKline Plc Corporate Summary
7.5.2 GlaxoSmithKline Plc Business Overview
7.5.3 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Major Product Offerings
7.5.4 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales and Revenue in Global (2017-2022)
7.5.5 GlaxoSmithKline Plc Key News
7.6 Humanigen Inc
7.6.1 Humanigen Inc Corporate Summary
7.6.2 Humanigen Inc Business Overview
7.6.3 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Major Product Offerings
7.6.4 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales and Revenue in Global (2017-2022)
7.6.5 Humanigen Inc Key News
7.7 Mologen AG
7.7.1 Mologen AG Corporate Summary
7.7.2 Mologen AG Business Overview
7.7.3 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Major Product Offerings
7.7.4 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales and Revenue in Global (2017-2022)
7.7.5 Mologen AG Key News
7.8 Morphotek Inc
7.8.1 Morphotek Inc Corporate Summary
7.8.2 Morphotek Inc Business Overview
7.8.3 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Major Product Offerings
7.8.4 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales and Revenue in Global (2017-2022)
7.8.5 Morphotek Inc Key News
7.9 Sillajen Biotherapeutics
7.9.1 Sillajen Biotherapeutics Corporate Summary
7.9.2 Sillajen Biotherapeutics Business Overview
7.9.3 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Major Product Offerings
7.9.4 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales and Revenue in Global (2017-2022)
7.9.5 Sillajen Biotherapeutics Key News
7.10 Takeda Pharmaceutical Co Ltd
7.10.1 Takeda Pharmaceutical Co Ltd Corporate Summary
7.10.2 Takeda Pharmaceutical Co Ltd Business Overview
7.10.3 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Major Product Offerings
7.10.4 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales and Revenue in Global (2017-2022)
7.10.5 Takeda Pharmaceutical Co Ltd Key News
8 Global Granulocyte Macrophage Colony Stimulating Factor Production Capacity, Analysis
8.1 Global Granulocyte Macrophage Colony Stimulating Factor Production Capacity, 2017-2028
8.2 Granulocyte Macrophage Colony Stimulating Factor Production Capacity of Key Manufacturers in Global Market
8.3 Global Granulocyte Macrophage Colony Stimulating Factor Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Granulocyte Macrophage Colony Stimulating Factor Supply Chain Analysis
10.1 Granulocyte Macrophage Colony Stimulating Factor Industry Value Chain
10.2 Granulocyte Macrophage Colony Stimulating Factor Upstream Market
10.3 Granulocyte Macrophage Colony Stimulating Factor Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Granulocyte Macrophage Colony Stimulating Factor Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com